Nanogen's total revenues for the period ended Sept. 30 increased 191 percent to $3.2 million from $1.1 million in the comparable quarter last year, the company said. Nanogen reported $1.1 million in product revenue for the third quarter of 2005, compared to $671,000 during the same period in 2004.
R&D spending in the period increased 26.7 percent to $5.7 million from $4.5 million year over year.
Nanogen's net loss fell to $8.8 million, or $0.18, from $9.4 million, or $.28 per share year over year.
The company had cash, equivalents, and short-term investments totaling $40.7 million at the end of the recent quarter.